SCHEMBL5564627

SCHEMBL5564627

NS(=O)(=O)c1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 13/20 0.64
CA2 P00918 13/20 0.64
CA9 Q16790 12/20 0.64
CA12 O43570 7/20 0.57
CA4 P22748 2/20 0.57
CA6 P23280 2/20 0.57
CA5A P35218 2/20 0.57
CA7 P43166 2/20 0.57
CA14 Q9ULX7 2/20 0.57
CA5B Q9Y2D0 2/20 0.57
LMNA P02545 1/20 0.57
CYP2C9 P11712 1/20 0.57
CA13 Q8N1Q1 1/20 0.57
POLB P06746 1/20 0.57
APEX1 P27695 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
THRB P10828 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9463563 0.89 CA1 (0.63) CA1CA2CA9CA12CA4
SCHEMBL6906930 0.87 CA1 (0.69) CA1CA2CA9CA12CA4
SCHEMBL29780561 0.86 CA2 (0.65) CA1CA2CA9CA12CA4
SCHEMBL7993257 0.80 CA2 (0.75) CA1CA2CA9CA12CA4
SCHEMBL8459698 0.80 HSD17B10 (0.50) CA1CA2CA9CA12CYP2C9
SCHEMBL1347471 0.80 HSD17B10 (0.50) CA1CA2CA9CA12CYP2C9
SCHEMBL1056064 0.78 HSD17B10 (0.48) CA1CA2CA9CYP2C9TDP1
SCHEMBL3857115 0.78 ING2 (0.52) CA1CA2CA9LMNACYP2C9
SCHEMBL3781532 0.78 CA1 (1.00) CA1CA2CA9CA12CA4
SCHEMBL1803937 0.77 PTGS1 (0.66) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1610753-A4 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC (US) 2007-07-04 EP disclosed
EP-1610753-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2006-01-04 EP disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed
US-5189094-A Reacting a poly(cyclic iminoether), and ethylenically unsaturated compounds TEIJIN LIMITED (JP) 1993-02-23 US disclosed
US-4931512-A REACTING POLY(CYCLIC IMINOETHER) WITH POLYOLS OR POLYAMINES, ACID CATALYST; CURABLE TEIJIN LIMITED (JP) 1990-06-05 US disclosed
US-4910265-A Poly(cyclic iminoether) and an acid catalyst TEIJIN LIMITED (JP) 1990-03-20 US disclosed
EP-0336390-A2 Process for producing thermoset resin TEIJIN LIMITED (JP) 1989-10-11 EP disclosed
EP-0273368-A2 Process for producing thermoset resin TEIJIN LIMITED (JP) 1988-07-06 EP disclosed